Citadel Advisors LLC trimmed its position in shares of Teleflex Incorporated (NYSE:TFX) by 59.0% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 60,797 shares of the medical technology company’s stock after selling 87,467 shares during the period. Citadel Advisors LLC’s holdings in Teleflex were worth $16,307,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. increased its holdings in shares of Teleflex by 4.9% during the 1st quarter. BlackRock Inc. now owns 4,940,818 shares of the medical technology company’s stock worth $1,259,811,000 after buying an additional 231,477 shares during the last quarter. American Century Companies Inc. increased its holdings in Teleflex by 1.0% in the 1st quarter. American Century Companies Inc. now owns 1,489,678 shares of the medical technology company’s stock valued at $379,838,000 after purchasing an additional 15,069 shares in the last quarter. Summit Trail Advisors LLC increased its holdings in Teleflex by 23,599.0% in the 1st quarter. Summit Trail Advisors LLC now owns 1,181,159 shares of the medical technology company’s stock valued at $1,181,000 after purchasing an additional 1,176,175 shares in the last quarter. USS Investment Management Ltd increased its holdings in Teleflex by 44.9% in the 1st quarter. USS Investment Management Ltd now owns 579,590 shares of the medical technology company’s stock valued at $155,310,000 after purchasing an additional 179,600 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its holdings in Teleflex by 0.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 548,319 shares of the medical technology company’s stock valued at $147,064,000 after purchasing an additional 1,783 shares in the last quarter. Institutional investors and hedge funds own 88.80% of the company’s stock.

NYSE:TFX opened at $248.81 on Friday. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.21 and a quick ratio of 1.45. The stock has a market capitalization of $11.36 billion, a price-to-earnings ratio of 29.62, a PEG ratio of 1.74 and a beta of 1.20. Teleflex Incorporated has a 1-year low of $203.70 and a 1-year high of $288.78.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, August 2nd. The medical technology company reported $2.47 earnings per share for the quarter, beating analysts’ consensus estimates of $2.41 by $0.06. The company had revenue of $609.87 million during the quarter, compared to analysts’ expectations of $615.97 million. Teleflex had a net margin of 3.78% and a return on equity of 17.32%. The firm’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the prior year, the company posted $2.04 EPS. sell-side analysts expect that Teleflex Incorporated will post 9.82 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 14th. Shareholders of record on Wednesday, August 15th will be given a $0.34 dividend. The ex-dividend date of this dividend is Tuesday, August 14th. This represents a $1.36 dividend on an annualized basis and a yield of 0.55%. Teleflex’s payout ratio is currently 16.19%.

In other news, VP John Deren sold 1,347 shares of the stock in a transaction dated Tuesday, June 12th. The shares were sold at an average price of $284.57, for a total transaction of $383,315.79. Following the transaction, the vice president now owns 1,419 shares of the company’s stock, valued at $403,804.83. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Thomas E. Powell sold 5,200 shares of the stock in a transaction dated Friday, June 22nd. The stock was sold at an average price of $281.60, for a total transaction of $1,464,320.00. Following the transaction, the insider now directly owns 17,083 shares in the company, valued at approximately $4,810,572.80. The disclosure for this sale can be found here. Over the last three months, insiders sold 74,002 shares of company stock valued at $19,558,163. 2.56% of the stock is currently owned by corporate insiders.

TFX has been the subject of several recent research reports. Needham & Company LLC lowered their price target on Teleflex from $298.00 to $279.00 and set a “buy” rating for the company in a report on Friday, August 3rd. Leerink Swann increased their price target on Teleflex from $309.00 to $317.00 and gave the company an “outperform” rating in a report on Tuesday, June 5th. Morgan Stanley lowered their price target on Teleflex from $310.00 to $295.00 and set an “overweight” rating for the company in a report on Friday, August 3rd. ValuEngine downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Friday, August 3rd. Finally, TheStreet downgraded Teleflex from a “b” rating to a “c+” rating in a report on Friday, August 3rd. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $281.10.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Featured Article: Find a Trading Strategy That Works

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.